Blood Test Predicts Treatment Response, Survival in Metastatic Disease

June 29, 2018 | Media Relations

PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study.

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.